Hamlet Pharma Overview

  • Founded
  • 1999

Founded
  • Status
  • Public

  • Employees
  • 5

Employees
  • Stock Symbol
  • HAMLET B

Stock Symbol
  • Share Price
  • $0.29

  • (As of Monday Closing)

Hamlet Pharma General Information

Description

Hamlet Pharma AB is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SAT
Primary Office
  • BMC D10
  • Klinikgatan 32
  • 222 42 Lund
  • Sweden
+46 040-12 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hamlet Pharma Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.29 $0.30 $0.27 - $0.82 $34.5M 111M 38K -$0.01

Hamlet Pharma Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019
EV 57,477 95,786 71,952 89,942
Revenue 0 0 0 0
EBITDA (1,103) (870) (2,424) (1,833)
Net Income (1,139) (900) (2,429) (1,868)
Total Assets 4,602 1,494 1,559 1,216
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hamlet Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hamlet Pharma‘s full profile, request access.

Request a free trial

Hamlet Pharma Patents

Hamlet Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202015836-D0 Compositions Inactive 06-Oct-2020 000000000
GB-202004013-D0 Therapy Inactive 19-Mar-2020
GB-201911948-D0 Therapy Inactive 20-Aug-2019
EP-4017522-A1 Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy Pending 20-Aug-2019 000000000
GB-201810108-D0 Therapeutically active complexes Inactive 20-Jun-2018 A61K38/17
To view Hamlet Pharma’s complete patent history, request access »

Hamlet Pharma Executive Team (4)

Name Title Board Seat Contact Info
Fredrik Herslow Chief Executive Officer
Martin Erixon Chief Executive Officer
Catharina Svanborg Founder, Chief Medical Officer & Chairman
You’re viewing 3 of 4 executive team members. Get the full list »

Hamlet Pharma Board Members (1)

Name Representing Role Since
0000 000000 00.0 Self Board Member 000 0000
To view Hamlet Pharma’s complete board members history, request access »

Hamlet Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial